Schroders Capital Global Innovation Trust plc - INOV

Formerly Schroder UK Public Private Trust plc (SUPP)

During the last quarter of 2024 the Board and Manager carried out an extensive shareholder consultation on proposals to bring forward the Company’s continuation vote and change to the Investment Objective and Policy.  These proposals received strong support from Shareholders at the General Meeting held on 27 February 2025 and resulted in the following amended Investment Objective and Policy:

Investment Objective

The Company’s investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company’s portfolio in an orderly manner.

Investment Policy

The assets of the Company will be realised in an orderly manner, with a view to achieving a balance between returning cash to Shareholders in a timely manner and maximising value.

The Company may not make any new investments save that:

  • Investments may be made to honour commitments under existing contractual arrangements or, with the Board’s prior written approval, into any existing investment; and
  • Cash held by the Company pending distribution will be held in either cash or cash equivalents for the purposes of cash management.

Any amounts received by the Company during the orderly realisation of the Company’s assets will be held by the Company as cash on deposit and/or as cash equivalents, prior to returns being made in cash to Shareholders (net of provisions for the Company’s costs and expenses). The Company will continue to comply with the requirements imposed by the Listing Rules in force from time to time. The Company will not employ gearing for investment purposes, but may utilise gearing for working capital purposes, subject to a cap on gearing of 10 per cent. Of NAV at the time of borrowing. Any material change to the Company’s published investment policy will be made only with the prior approval of the FCA and of Shareholders by ordinary resolution at a general meeting of the Company.

Principles of an 'orderly managed wind down'

Maximise exit value

Focus on maintaining or increasing the value of the portfolio and avoiding where possible quick, value destructive exit options (e.g. heavily discounted portfolio secondaries)

Support (not force) exit events

Focus on exits that align with planned company events (e.g. trade sales or IPOs)

Prudent reserving

Establish a cash management plan that balances the desire for timely distributions with ensuring liquidity is available to support the portfolio, meet ongoing operating costs and address unforeseen circumstances

On 28 March 2025, Managers Tim Creed and Harry Raikes presented the Trust's annual results for the year ended 31 December 2024

Annual Results 2024

Regulatory News Feed

Portfolio Company Updates

Slide 1 of 12
Taiho Pharmaceutical to acquire Araris Biotech
Anthos Therapeutics sold to Novartis for up to $3.1bn.
Revolut receives UK banking licence
Revolut’s revenues surpass $2.2bn, with record profits of $545m in 2023
Neurona receives accelerated FDA approval for lead product candidate
Acquisition of Carmot by Roche
Acquisition of Kymab by Sanofi
Oxford Nanopore to 'soar to heady heights' despite 'discount to US counterparts'
Nexeon enters into long-term supply agreement with Panasonic Energy
Autolus presents positive results from pivotal phase 2 FELIX study
A2 Bio announces first patient dosed in phase 1 clinical trial
Reaction Engines: Announcement of £40m/$47.7m Funding Round

Performance

For further performance data please visit the London Stock Exchange website
Ongoing charge: 0.98%
Performance fee: None until end-2022, then 15% of any gain in the NAV (Net Asset Value) above 77p, and subsequently 15% of any gain above 10% per annum.

Trust press

Slide 1 of 9
Citywire: Schroders Capital Global’s bumper first sale after wind-down vote
INOV’s Harry Raikes included in RealDeals’ Future 40 list
Citywire: Schroders’ Global Innovation trust bags 221% Carmot gain
Schroders Capital Global Innovation gets sale milestone fee
Schroder UK Public Private backs Indian AgTech start-up
INVESTMENTWEEK: Schroder UK Public Private's Creed defends global remit change
AssetTV: Investment Trust Outlook - UK Equities
QuotedData Weekly Show: Interview with Tim Creed
Investors Chronicle: Podcast with Tim Creed

The Portfolio Managers

ㅤ‎

Tim Creed

Lead Co-Portfolio Manager, Head of Private Equity Investments, Schroders Capital

Harry Raikes

Co-Portfolio Manager

Documents

Annual Report and Accounts 2024
Interim Report & Accounts 2024
Results of General Meeting: February 2025
Circular and Notice of General Meeting
Articles of Association - Updated February 2025
Auditor Resignation
Winterflood (Sponsor) Consent Letter
Privacy Policy
Terms of Reference: Management Engagement Committee
Terms of Reference: Nomination Committee
Terms of Reference: Audit and Risk Committee
Responsibilities of the Chair of the Board
Responsibilities of the Senior Independent Directors
Pre-investment AIFMD Disclosure

Archive

Annual Reports & Accounts

2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015

Interim Reports & Accounts

2024 / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015

AGM Results

2024 / 2023 / 2021

Non-Mainstream Pooled Investments (NMPI) Status

The Company currently conducts its affairs so that its shares can be recommended by IFAs to ordinary retail investors in accordance with the FCA's rules in relation to non-mainstream investment products and intends to continue to do so for the foreseeable future. The Company's shares are excluded from the FCA's restrictions which apply to non-mainstream investment products because they are shares in an investment trust.

Fund Risk Considerations: Schroders Capital Global Innovation Trust plc

  • Concentration risk: The Company may be concentrated in a limited number of geographical regions, industry sectors, markets and/or individual positions. This may result in large changes in the value of the company, both up or down.
  • Counterparty risk: The Company may have contractual agreements with counterparties. If a counterparty is unable to fulfil their obligations, the sum that they owe to the Company may be lost in part or in whole.

  • Currency risk: If the Company’s investments are denominated in currencies different to the currency of the Company’s shares, the Company may lose value as a result of movements in foreign exchange rates, otherwise known as currency rates.

  • Derivatives risk: Derivatives, which are financial instruments deriving their value from an underlying asset, may be used to manage the portfolio efficiently. A derivative may not perform as expected, may create losses greater than the cost of the derivative and may result in losses to the Company.

  • Emerging markets & frontier risk: Emerging markets, and especially frontier markets, generally carry greater political, legal, counterparty, operational and liquidity risk than developed markets.

  • Gearing risk​: The Company may borrow money to make further investments, this is known as gearing. Gearing will increase returns if the value of the investments purchased increase by more than the cost of borrowing, or reduce returns if they fail to do so. In falling markets, the whole of the value in such investments could be lost, which would result in losses to the Company.

  • Liquidity Risk: The price of shares in the Company is determined by market supply and demand, and this may be different to the net asset value of the Company. In difficult market conditions, investors may not be able to find a buyer for their shares or may not get back the amount that they originally invested. Certain investments of the Company, in particular the unquoted investments, may be less liquid and more difficult to value. In difficult market conditions, the Company may not be able to sell an investment for full value or at all and this could affect performance of the Company.

  • Market risk: The value of investments can go up and down and an investor may not get back the amount initially invested.

  • Market Risk: The value of investments can go up and down and an investor may not get back the amount initially invested.

  • Operational risk​: Operational processes, including those related to the safekeeping of assets, may fail. This may result in losses to the Company.

  • Performance risk: Investment objectives express an intended result but there is no guarantee that such a result will be achieved. Depending on market conditions and the macro economic environment, investment objectives may become more difficult to achieve.

  • Private market valuations, and pricing frequency: Valuation of private asset investments is performed less frequently than listed securities and may be performed less frequently than the valuation of the Company itself. In addition, in times of stress it may be difficult to find appropriate prices for these investments and they may be valued on the basis of proxies or estimates. These factors mean that there may be significant changes in the net asset value of the Company which may also affect the price of shares in the Company.

  • Share price risk: The price of shares in the Company is determined by market supply and demand, and this may be different to the net asset value of the Company. This means the price may be volatile, meaning the price may go up and down to a greater extent in response to changes in demand.

  • Smaller companies risk: Smaller companies generally carry greater liquidity risk than larger companies, meaning they are harder to buy and sell, and they may also fluctuate in value to a greater extent.